These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24704104)

  • 1. Regulatory perspectives on acceptability testing of dosage forms in children.
    Kozarewicz P
    Int J Pharm; 2014 Aug; 469(2):245-8. PubMed ID: 24704104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues impacting therapeutic outcomes in pediatric patients: an overview.
    Kalra A; Goindi S
    Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric formulation issues identified in Paediatric Investigation Plans.
    Quijano Ruiz B; Desfontaine E; Arenas-López S; Wang S
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):25-30. PubMed ID: 24308789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation factors affecting acceptability of oral medicines in children.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Kendall R; Tuleu C;
    Int J Pharm; 2015 Aug; 492(1-2):341-3. PubMed ID: 25959115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on taste masked multiparticulate dosage forms for paediatric.
    Al-Japairai K; Hamed Almurisi S; Almonem Doolaanea A; Mahmood S; Alheibshy F; Alobaida A; Abdul-Halim N; Chatterjee B
    Int J Pharm; 2023 Feb; 632():122571. PubMed ID: 36587776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-centred, administration friendly medicines for children - an evaluation of children's preferences and how they impact medication adherence.
    Bryson SP
    Int J Pharm; 2014 Aug; 469(2):257-9. PubMed ID: 24797763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.
    Ternik R; Liu F; Bartlett JA; Khong YM; Thiam Tan DC; Dixit T; Wang S; Galella EA; Gao Z; Klein S
    Int J Pharm; 2018 Feb; 536(2):570-581. PubMed ID: 28844897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms - an application for paediatric dosage form selection.
    Sam T; Ernest TB; Walsh J; Williams JL;
    Int J Pharm; 2012 Oct; 435(2):115-23. PubMed ID: 22626885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of different oral dosage forms in paediatric patients in hospital setting.
    Pokharkar V; Sajith M; Vallet T; Akshantal S; Shah R; Ruiz F; Salunke S
    Arch Dis Child; 2022 Sep; 107(9):796-801. PubMed ID: 34799375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of medicines for children.
    Nunn T; Williams J
    Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicines for children: a matter of taste.
    Davies EH; Tuleu C
    J Pediatr; 2008 Nov; 153(5):599-604, 604.e1-2. PubMed ID: 18940350
    [No Abstract]   [Full Text] [Related]  

  • 14. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 15. A spoonful of sugar helps the medicine go down? Perspectives on the use of sugar in children's medicines.
    Manley MC; Calnan M; Sheiham A
    Soc Sci Med; 1994 Sep; 39(6):833-40. PubMed ID: 7973879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations.
    Walsh J; Ranmal SR; Ernest TB; Liu F
    Int J Pharm; 2018 Feb; 536(2):547-562. PubMed ID: 28705619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodology Used to Assess Acceptability of Oral Pediatric Medicines: A Systematic Literature Search and Narrative Review.
    Mistry P; Batchelor H;
    Paediatr Drugs; 2017 Jun; 19(3):223-233. PubMed ID: 28413843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary--Formulating better medicines for children.
    Salunke S; Hempenstall J; Kendall R; Roger B; Mroz C; Nunn T; Tuleu C
    Int J Pharm; 2011 Oct; 419(1-2):235-9. PubMed ID: 21784141
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients' appropriateness, acceptability, usability and preferences for pharmaceutical preparations: Results from a literature review on clinical evidence.
    Drumond N; van Riet-Nales DA; Karapinar-Çarkit F; Stegemann S
    Int J Pharm; 2017 Apr; 521(1-2):294-305. PubMed ID: 28229945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.